|
|
||||||||
Technical Briefs |
1
Ist. Istol. & Anal. Lab., Facoltà Sci., MFN Università, Via E. Zeppi, 61029 Urbino, Italia;
2
Div. Med., and
3
Lab. Anal. Ospedale Civile, Urbino, Italia;
a author for
correspondence: fax +39-722-322370, e-mail citometria@fis.uniurb.it
Prostate-specific antigen (PSA) is a serine protease, first
identified in 1970 (1) and nowadays widely used for early
detection and monitoring of prostate cancer (2). Although
previously thought to be produced exclusively by the epithelial cells
of the prostate (3), at present PSA is considered a
widespread biochemical marker produced and secreted in several
biological fluids, by both normal and tumor tissues (e.g.,
(4)(5)(6)(7)(8)(9)(10)(11)(12)). In blood, complexes form between PSA
and serine protease inhibitors, such as
1-antichymotrypsin and
2-macroglobulin
(2)(3)(4). Free PSA also exists in serum, even
though its increased concentration in female serum is a matter of
recent debate (12)(13)(14)(15)(16).
Considering the immunoreactivity of PSA in tumors of the lung
(7)(8), we undertook the study of the PSA
distribution and expression in pleural effusions collected from 68
women, ages 60 ± 11
References
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |